Compositions and methods for treating immune conditions, including type 1 diabetes
OwnerJan CZYZYKinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides a vaccine, immunogenic polypeptide, and pharmaceutical compound, all including a serpinB13 protein or polypeptide or an immunogenic polypeptide that includes a serpinB13 protein or polypeptide coupled to an immunogenic agent. The present invention further includes use of these agents according to a method of inhibiting or delaying onset, or reducing the severity of type 1 diabetes, as well as a method of treating an individual for an immune condition selected from the group of psoriasis, hair loss, and ulcers including diabetic food ulceration.
Claims28
An immunogenic composition comprising a pharmaceutically acceptable carrier and a serpinB13 protein or polypeptide.
An immunogenic polypeptide comprising a serpinB13 protein or polypeptide coupled to an immunogenic agent.
-15. (canceled)
-20. (canceled)
-27. (canceled)
-43. (canceled)
-49. (canceled)
Dependencies are inferred from the claim text.